Our exome wide biomarkers study identified 4 SNPs [SNRK and SNRK-AS1-rs202018563G; BRCA2-rs2227943C; ZNF484-rs199826847C; and DCPS-rs1695739G] as the most significant SNPs among our patients with breast cancer compared to the healthy controls. This evidence concerns the gene ZNF484 and breast cancer.